Skip to main content

Table 2 Demographic characteristics of interview participants

From: Using a qualitative sub-study to inform the design and delivery of randomised controlled trials on medicinal cannabis for symptom relief in patients with advanced cancer

Characteristic

Interview participants

Trial participant (n = 28)

Declined trial participation (n = 20)

Total (n = 48)

Gender, % (n)

 Male

25% (12)

22.91% (11)

47.91% (23)

 Female

33.33% (16)

18.75% (9)

52.08% (25)

Age in years, % (n)

 ≤49

6.25% (3)

 

6.25% (3)

 50–69

31.25% (15)

20.8% (9)

50% (24)

 70–89

20.83% (10)

22.91% (11)

43.75% (21)

Household arrangements, % (n)

 Living with others (e.g. spouse, children)

54.17% (26)

31.25% (15)

85.42% (41)

 Living alone

4.16% (2)

10.42% (5)

14.58% (7)

Ethnicity, % (n)

 Anglo-Saxon/English

35.41% (17)

37.5% (18)

72.92% (35)

 Australian

6.25% (3)

 

6.25% (3)

 Pacific Islander

6.25% (3)

 

6.35% (3)

 Australasian

2.08% (1)

 

2.08% (1)

 Scottish

2.08% (1)

 

2.08% (1)

 Undisclosed

6.25% (3)

1.16% (2)

10.41% (5)

Education level, % (n)

 Did not complete high school

6.25% (3)

 

6.25% (3)

 High school

50% (24)

33.33% (16)

83.33% (40)

 Bachelor’s degree

 

2.08% (1)

2.08% (1)

 Unknown

2.08% (1)

6.25% (3)

8.33% (4)

Primary cancer diagnosis, % (n)

 Breast

12.5% (6)

12.5% (6)

25% (12)

 Prostate

6.25% (3)

14.58% (7)

20.83% (10)

 Lung

8.33% (4)

6.25% (3)

14.58% (7)

 Ovarian

6.25% (3)

 

6.25% (3)

 Endometrial

6.25% (3)

 

6.25% (3)

 Urothelial

 

4.16% (2)

4.16% (2)

 Colorectal/rectal

4.16% (2)

 

4.16% (2)

 Pancreatic

4.16% (2)

 

4.16% (2)

 Other

10.42% (5)

4.16% (2)

14.58% (7)